UCL scientists have successfully completed the first human trial of the drug that targets the cause of Huntington’s disease. After over a decade in pre-clinical …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
